• OPEN AN ACCOUNT
Indian Indices
Sensex
76,835.78 776.01
( 1.02%)
Global Indices
Nasdaq
51,969.87 237.22
(0.46%)
Dow Jones
7,434.30 5.00
(0.07%)
Hang Seng
64,889.11 277.96
(0.43%)
Nikkei 225
10,738.51 99.34
(0.93%)
Forex
USD-INR
96.67 0.19
(0.20%)
EUR-INR
110.18 0.12
(0.10%)
GBP-INR
129.04 -0.01
(0.00%)
JPY-INR
0.59 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Valiant Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543998
INE0JWS01017
58.8745685
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VALIANTLAB
58.99
326.8
EPS(TTM)
Face Value()
Div & Yield %
1.02
10
0
 

hindustan unilever ltd
Vivanta Industries reports consolidated net loss of Rs 0.80 crore in the March 2026 quarter
May 29,2026
Net Loss of Vivanta Industries reported to Rs 0.80 crore in the quarter ended March 2026 as against net loss of Rs 1.65 crore during the previous quarter ended March 2025. Sales declined 62.45% to Rs 38.25 crore in the quarter ended March 2026 as against Rs 101.87 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 0.60 crore in the year ended March 2026 as against net loss of Rs 1.32 crore during the previous year ended March 2025. Sales rose 127.77% to Rs 250.09 crore in the year ended March 2026 as against Rs 109.80 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales38.25101.87 -62 250.09109.80 128
OPM %-3.40-1.54 --0.76-1.28 -
PBDT-0.29-1.54 81 1.27-0.91 LP
PBT-0.53-1.64 68 0.88-1.32 LP
NP-0.80-1.65 52 0.60-1.32 LP